As­traZeneca asks fed­er­al judge to de­cide in its fa­vor in drug price ne­go­ti­a­tions law­suit

Law­suits over the In­fla­tion Re­duc­tion Act’s drug price ne­go­ti­a­tions are pick­ing up, with lawyers for As­traZeneca and the gov­ern­ment duk­ing it out in Delaware fed­er­al court in re­cent fil­ings.

On Mon­day, As­traZeneca asked a fed­er­al judge to de­cide in its fa­vor with­out a full tri­al, ar­gu­ing that it “faces con­crete and im­mi­nent in­juries that di­rect­ly re­sult from the un­con­sti­tu­tion­al as­pects of the Drug Price Ne­go­ti­a­tion Pro­gram, and they are re­dress­able by this Court.”

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER